跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pravaz - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Pravaz
Approved
STANDARD
Pravaz
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
77a24569252cb7de
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
77a24569252cb7de
Drug Approval Philippines Name
Pravaz
Product Name
Pravaz
Registration Number
DRP-10005
Brand Name
Pravaz
Generic Name
Pravastatin (as Sodium)
Dosage Form
Tablet
Dosage Strength
40 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
29 May 2024
Expiry Date
31 July 2029
Pharmacologic Category
HMG-CoA Reductase Inhibitor/Antihyperlipidemic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
77a24569252cb7de
Type
Standard
Back to Philippines FDA Approvals